David Martín-Hernández

Dr. David Martín-Hernández

Salud mental, Centro de Investigación Biomédica en Red, Madrid, Spain
orcid

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
4 September 2018 in Journal of Neuroinflammation
Verified
Journal Article
Open access
PDF file
David Martín-HernándezDavid Martín-Hernández
David Martín-Hernández
JCJavier Caso
Javier Caso
JMJ Javier Meana
J Javier Meana
LCLuis Callado
Luis Callado
JMJose LM Madrigal
Jose LM Madrigal
JLJuan C. Leza
Juan C. Leza
Studies show that Toll-like receptors (TLRs), members of the innate immune system, might participate in the pathogenesis of the major depressive disorder (MDD). However, evidence of this participation in the brain of patients with MDD has been elusive. This work explores whether the protein expression by immunodetection assays (Western blot) of elements of TLR-4 pathways controlling inflammation and the oxidative/nitrosative stress are altered in postmortem dorsolateral prefrontal cortex of subjects with MDD. The potential modulation induced by the antidepressant treatment on these parameters was also assessed. Thirty MDD subjects (15 antidepressant-free and 15 under antidepressant treatment) were matched for gender and age to 30 controls in a paired design. No significant changes in TLR-4 expression were detected. An increased expression of the TLR-4 endogenous ligand Hsp70 (+ 33%), but not of Hsp60, and the activated forms of mitogen-activated protein kinases (MAPKs) p38 (+ 47%) and JNK (+ 56%) was observed in MDD. Concomitantly, MDD subjects present a 45% decreased expression of DUSP2 (a regulator of MAPKs) and reduced (− 21%) expression of the antioxidant nuclear factor Nrf2. Antidepressant treatment did not modify the changes detected in the group with MDD and actually increased (+ 25%) the expression of p11, a protein linked with the transport of neurotransmitters and depression. Data indicate an altered TLR-4 immune response in the brain of subjects with MDD. Additional research focused on the mechanisms contributing to the antidepressant-induced TLR-4 pathway modulation is warranted and could help to develop new treatment strategies for MDD.

1 March 2021 in Biochemical Pharmacology
Verified
Journal Article
Closed access
EFEva Florensa-Zanuy
Eva Florensa-Zanuy
EGEmilio Garro-Martínez
Emilio Garro-Martínez
AAAlbert Adell
Albert Adell
ECElena Castro
Elena Castro
ÁDÁlvaro Díaz
Álvaro Díaz
FPFUENCISLA PILAR-CUELLAR
FUENCISLA PILAR-CUELLAR

3 May 2018 in Molecular Neurobiology
Verified
Journal Article
Closed access
PDF file
David Martín-HernándezDavid Martín-Hernández
David Martín-Hernández
Hiram Tendilla-BeltránHiram Tendilla-Beltrán
Hiram Tendilla-Beltrán
JMJose LM Madrigal
Jose LM Madrigal
BGBorja García-Bueno
Borja García-Bueno
JLJuan C. Leza
Juan C. Leza
JCJavier Caso
Javier Caso

12 January 2021 in Journal of Clinical Periodontology
Verified
Journal Article
Closed access
PDF file
MMMaría Martínez
María Martínez
David Martín-HernándezDavid Martín-Hernández
David Martín-Hernández
LVLeire Virto
Leire Virto
KMKarina S. MacDowell
Karina S. MacDowell
EMEduardo Montero
Eduardo Montero
EFElena Figuero
Elena Figuero

1 April 2016 in Neuropharmacology
Verified
Journal Article
Closed access
David Martín-HernándezDavid Martín-Hernández
David Martín-Hernández
JCJavier Caso
Javier Caso
ÁBÁlvaro G. Bris
Álvaro G. Bris
SMSandra R. Maus
Sandra R. Maus
JMJose LM Madrigal
Jose LM Madrigal
JLJuan C. Leza
Juan C. Leza

1 October 2016 in Neurotherapeutics
Verified
Journal Article
Open access
PDF file
KMKarina S. MacDowell
Karina S. MacDowell
JCJavier Caso
Javier Caso
David Martín-HernándezDavid Martín-Hernández
David Martín-Hernández
BMBeatriz M. Moreno
Beatriz M. Moreno
JMJose LM Madrigal
Jose LM Madrigal
BGBorja García-Bueno
Borja García-Bueno
Alterations in the innate inflammatory response may underlie the pathophysiology of psychiatric diseases. Current antipsychotics modulate pro-/anti-inflammatory pathways, but their specific actions on these pathways remain only partly explored. This study was conducted to elucidate the regulatory role of paliperidone (1 mg/kg i.p.) on acute (6 h) and chronic (6 h/day for 21 consecutive days) restraint stress-induced alterations in 2 emerging endogenous anti-inflammatory/antioxidant mechanisms: nuclear factor erythroid-related factor 2 (NRF2)/antioxidant enzymes pathway, and the cytokine milieu regulating M1/M2 polarization in microglia, analyzed at the mRNA and protein levels in prefrontal cortex samples. In acute stress conditions, paliperidone enhanced NRF2 levels, possibly related to phosphoinositide 3-kinase upregulation and reduced kelch-Like ECH-associated protein 1 expression. In chronic conditions, paliperidone tended to normalize NRF2 levels through a phosphoinositide 3-kinase related-mechanism, with no effects on kelch-Like ECH-associated protein 1. Antioxidant response element-dependent antioxidant enzymes were upregulated by paliperidone in acute stress, while in chronic stress, paliperidone tended to prevent stress-induced downregulation of the endogenous antioxidant machinery. However, paliperidone increased transforming growth factor-β and interleukin-10 in favor of an M2 microglia profile in acute stress conditions, which was also corroborated by paliperidone-induced increased levels of the M2 cellular markers arginase I and folate receptor 2. This latter effect was also produced in chronic conditions. Immunofluorescence studies suggested an increase in the number of microglial cells expressing arginase I and folate receptor 2 in the stressed animals pretreated with paliperidone. In conclusion, the enhancement of endogenous antioxidant/anti-inflammatory pathways by current and new antipsychotics could represent an interesting therapeutic strategy for the future.